Sep 09, 2021 / 12:00PM GMT
Presentation
Sep 09, 2021 / 12:00PM GMT
=====================
Corporate Participants
=====================
* Adrian G. Rawcliffe
Adaptimmune Therapeutics plc - CEO, Principal Accounting Officer & Director
* Helen Katrina Tayton-Martin
Adaptimmune Therapeutics plc - Co-Founder & Chief Business Officer
* Joanna Brewer
Adaptimmune Therapeutics plc - SVP of Allogeneic Research
* William C. Bertrand
Adaptimmune Therapeutics plc - COO
=====================
Adrian G. Rawcliffe - Adaptimmune Therapeutics plc - CEO, Principal Accounting Officer & Director
Hi. I'm Ad Rawcliffe, Adaptimmune's CEO. Before I start, I want to touch on 2 things. Firstly, I'll refer you to this disclaimer slide as our presentation today contains forward-looking statements. And secondly, I want to remind everyone we have a Q&A session at the end of this virtual event. You can use the Q&A function in your Zoom meeting portal to send through questions as shown here by the arrow to the right.
I'd like to have
Adaptimmune Therapeutics PLC Strategic Collaboration with Genentech Inc Presentation Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot